|
1
|
Allemani C, Weir HK, Carreira H, Harewood
R, Spika D, Wang XS, Bannon F, Ahn JV, Johnson CJ, Bonaventure A,
et al CONCORD Working Group: Global surveillance of cancer survival
1995-2009: Analysis of individual data for 25,676,887 patients from
279 population-based registries in 67 countries (CONCORD-2).
Lancet. 385:977–1010. 2015. View Article : Google Scholar
|
|
2
|
Langer CJ, Besse B, Gualberto A, Brambilla
E and Soria JC: The evolving role of histology in the management of
advanced non-small-cell lung cancer. J Clin Oncol. 28:5311–5320.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Perlikos F, Harrington KJ and Syrigos KN:
Key molecular mechanisms in lung cancer invasion and metastasis: A
comprehensive review. Crit Rev Oncol Hematol. 87:1–11. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kalluri R and Zeisberg M: Fibroblasts in
cancer. Nat Rev Cancer. 6:392–401. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shekhar MP, Pauley R and Heppner G: Host
microenvironment in breast cancer development: Extracellular
matrix-stromal cell contribution to neoplastic phenotype of
epithelial cells in the breast. Breast Cancer Res. 5:130–135. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Olaso E, Salado C, Egilegor E, Gutierrez
V, Santisteban A, Sancho-Bru P, Friedman SL and Vidal-Vanaclocha F:
Proangiogenic role of tumor-activated hepatic stellate cells in
experimental melanoma metastasis. Hepatology. 37:674–685. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
De Wever O and Mareel M: Role of tissue
stroma in cancer cell invasion. J Pathol. 200:429–447. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ostman A and Augsten M: Cancer-associated
fibroblasts and tumor growth–bystanders turning into key players.
Curr Opin Genet Dev. 19:67–73. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xing F, Saidou J and Watabe K: Cancer
associated fibroblasts (CAFs) in tumor microenvironment. Front
Biosci. 15:166–179. 2010. View
Article : Google Scholar :
|
|
12
|
Unger C, Kramer N, Unterleuthner D,
Scherzer M, Burian A, Rudisch A, Stadler M, Schlederer M, Lenhardt
D, Riedl A, et al: Stromal-derived IGF2 promotes colon cancer
progression via paracrine and autocrine mechanisms. Oncogene.
36:5341–5355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Teng F, Tian WY, Wang YM, Zhang YF, Guo F,
Zhao J, Gao C and Xue FX: Cancer-associated fibroblasts promote the
progression of endometrial cancer via the SDF-1/CXCR4 axis. J
Hematol Oncol. 9:82016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kuzet SE and Gaggioli C: Fibroblast
activation in cancer: When seed fertilizes soil. Cell Tissue Res.
365:607–619. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Neri S, Hashimoto H, Kii H, Watanabe H,
Masutomi K, Kuwata T, Date H, Tsuboi M, Goto K, Ochiai A, et al:
Cancer cell invasion driven by extracellular matrix remodeling is
dependent on the properties of cancer-associated fibroblasts. J
Cancer Res Clin Oncol. 142:437–446. 2016. View Article : Google Scholar
|
|
16
|
Stein U, Walther W, Arlt F, Schwabe H,
Smith J, Fichtner I, Birchmeier W and Schlag PM: MACC1, a newly
identified key regulator of HGF-MET signaling, predicts colon
cancer metastasis. Nat Med. 15:59–67. 2009. View Article : Google Scholar
|
|
17
|
Arlt F and Stein U: Colon cancer
metastasis: MACC1 and Met as metastatic pacemakers. Int J Biochem
Cell Biol. 41:2356–2359. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang L, Wu Y, Lin L, Liu P, Huang H, Liao
W, Zheng D, Zuo Q, Sun L, Huang N, et al: Metastasis-associated in
colon cancer-1 upregulation predicts a poor prognosis of gastric
cancer, and promotes tumor cell proliferation and invasion. Int J
Cancer. 133:1419–1430. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Huang Y, Zhang H, Cai J, Fang L, Wu J, Ye
C, Zhu X and Li M: Overexpression of MACC1 and Its significance in
human Breast Cancer Progression. Cell Biosci. 3:162013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ji D, Lu ZT, Li YQ, Liang ZY, Zhang PF, Li
C, Zhang JL, Zheng X and Yao YM: MACC1 expression correlates with
PFKFB2 and survival in hepatocellular carcinoma. Asian Pac J Cancer
Prev. 15:999–1003. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gao J, Ding F, Liu Q and Yao Y: Knockdown
of MACC1 expression suppressed hepatocellular carcinoma cell
migration and invasion and inhibited expression of MMP2 and MMP9.
Mol Cell Biochem. 376:21–32. 2013. View Article : Google Scholar
|
|
22
|
Shimokawa H, Uramoto H, Onitsuka T,
Chundong G, Hanagiri T, Oyama T and Yasumoto K: Overexpression of
MACC1 mRNA in lung adenocarcinoma is associated with postoperative
recurrence. J Thorac Cardiovasc Surg. 141:895–898. 2011. View Article : Google Scholar
|
|
23
|
Chundong G, Uramoto H, Onitsuka T,
Shimokawa H, Iwanami T, Nakagawa M, Oyama T and Tanaka F: Molecular
diagnosis of MACC1 status in lung adenocarcinoma by
immunohistochemical analysis. Anticancer Res. 31:1141–1145.
2011.PubMed/NCBI
|
|
24
|
Guo T, Kong J, Liu Y, Li Z, Xia J, Zhang
Y, Zhao S, Li F, Li J and Gu C: Transcriptional activation of NANOG
by YBX1 promotes lung cancer stem-like properties and metastasis.
Biochem Biophys Res Commun. 487:153–159. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang Z, Cai M, Weng Y, Zhang F, Meng D,
Song J, Zhou H and Xie Z: Circulating MACC1 as a novel diagnostic
and prognostic biomarker for nonsmall cell lung cancer. J Cancer
Res Clin Oncol. 141:1353–1361. 2015. View Article : Google Scholar
|
|
26
|
Yu T, Guo Z, Fan H, Song J, Liu Y, Gao Z
and Wang Q: Cancer-associated fibroblasts promote non-small cell
lung cancer cell invasion by upregulation of glucose-regulated
protein 78 (GRP78) expression in an integrated bionic microfluidic
device. Oncotarget. 7:25593–25603. 2016.PubMed/NCBI
|
|
27
|
Mueller MM and Fusenig NE: Friends or foes
- bipolar effects of the tumour stroma in cancer. Nat Rev Cancer.
4:839–849. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Friedl P, Noble PB, Walton PA, Laird DW,
Chauvin PJ, Tabah RJ, Black M and Zanker KS: Migration of
coordinated cell clusters in mesenchymal and epithelial cancer
explants in vitro. Cancer Res. 55:4557–4560. 1995.PubMed/NCBI
|
|
29
|
Friedl P, Locker J, Sahai E and Segall JE:
Classifying collective cancer cell invasion. Nat Cell Biol.
14:777–783. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Migliore C, Martin V, Leoni VP, Restivo A,
Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, et
al: MiR-1 downregulation cooperates with MACC1 in promoting MET
overexpression in human colon cancer. Clin Cancer Res. 18:737–747.
2012. View Article : Google Scholar
|
|
31
|
Galimi F, Torti D, Sassi F, Isella C, Corà
D, Gastaldi S, Ribero D, Muratore A, Massucco P, Siatis D, et al:
Genetic and expression analysis of MET, MACC1, and HGF in
metastatic colorectal cancer: Response to met inhibition in patient
xenografts and pathologic correlations. Clin Cancer Res.
17:3146–3156. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen S, Zong ZH, Wu DD, Sun KX, Liu BL and
Zhao Y: The role of metastasis-associated in colon cancer 1 (MACC1)
in endometrial carcinoma tumorigenesis and progression. Mol
Carcinog. 56:1361–1371. 2017. View
Article : Google Scholar
|
|
33
|
Zhou L, Yu L, Zhu B, Wu S, Song W, Gong X
and Wang D: Metastasis-associated in colon cancer-1 and aldehyde
dehydrogenase 1 are metastatic and prognostic biomarker for
non-small cell lung cancer. BMC Cancer. 16:8762016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tan W, Xie X, Li L, Tang H, Ye X, Chen L,
Tang W, Gao J, Pan L, Zhang X, et al: Diagnostic and prognostic
value of serum MACC1 in breast cancer patients. Oncotarget.
7:84408–84415. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang Y, Wang Z, Chen M, Peng L, Wang X,
Ma Q, Ma F and Jiang B: MicroRNA-143 targets MACC1 to inhibit cell
invasion and migration in colorectal cancer. Mol Cancer. 11:232012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Guo T, Zhao S, Wang P, Xue X, Zhang Y,
Yang M, Li N, Li Z, Xu L, Jiang L, et al: YB-1 regulates tumor
growth by promoting MACC1/c-Met pathway in human lung
adenocarcinoma. Oncotarget. 8:48110–48125. 2017.PubMed/NCBI
|
|
37
|
Gaggioli C, Hooper S, Hidalgo-Carcedo C,
Grosse R, Marshall JF, Harrington K and Sahai E: Fibroblast-led
collective invasion of carcinoma cells with differing roles for
RhoGTPases in leading and following cells. Nat Cell Biol.
9:1392–1400. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wu X, Chen X, Zhou Q, Li P, Yu B, Li J, Qu
Y, Yan J, Yu Y, Yan M, et al: Hepatocyte growth factor activates
tumor stromal fibroblasts to promote tumorigenesis in gastric
cancer. Cancer Lett. 335:128–135. 2013. View Article : Google Scholar : PubMed/NCBI
|
